Target intelligence / Profile preview

Gut and oral microbiome

Molecular classification
Other
01

Overview

The gut and oral microbiomes represent the complex communities of microorganisms, including bacteria, fungi, viruses, and archaea, inhabiting the gastrointestinal tract and oral cavity. These ecosystems play a fundamental role in human health by aiding in the digestion of complex carbohydrates, synthesizing essential vitamins like B12 and K, and training the host immune system to distinguish between commensals and pathogens [1, 2]. Dysbiosis, or an imbalance in these microbial populations, has been linked to a wide array of local and systemic conditions, ranging from periodontitis and inflammatory bowel disease to metabolic disorders and neurodegenerative diseases [3, 4]. Therapeutically, the microbiome is targeted through various interventions such as antibiotics, probiotics, prebiotics, and fecal microbiota transplantation (FMT) to restore a healthy microbial balance [5]. Emerging research also highlights the microbiome's influence on drug metabolism and the efficacy of cancer immunotherapies, making it a critical factor in personalized medicine [6].

Other names
Human microbiotaGastrointestinal microbiotaOral microbiotaCommensal floraMicrobial ecosystem
02

Mechanism of action

Modulation of microbial community composition and metabolic output, including the production of short-chain fatty acids (SCFAs) and secondary bile acids, to restore homeostatic interactions with the host immune and metabolic systems [5, 6].

03

Biological functions

Metabolic regulationImmune system modulationPathogen defenseVitamin synthesisMaintenance of mucosal barrier integrity
04

Disease associations

Inflammatory bowel diseaseObesityType 2 diabetesColorectal cancerPeriodontitisCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Risk of dysbiosisSystemic translocation of opportunistic pathogensTransfer of antibiotic resistance genesVariable patient response to microbial modulation
06

Interacting drugs

Amoxicillin

7 more in the full profile.

07

Biomarkers

Alpha diversity (Shannon index)Firmicutes/Bacteroidetes ratioAkkermansia muciniphila abundanceFecal calprotectinTrimethylamine N-oxide (TMAO) levels

Beyond the preview

Go deeper on Gut and oral microbiome.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut and oral microbiome.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call